CRF Health Unveils TrialMax ConMed™ for Oncology Trials

August 10, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

The identification of concomitant medication poses specific challenges in oncology data reporting.

CRF Health, a global provider of electronic Clinical  Outcome Assessment (eCOA) solutions introduced a complete TrialMax® eCOA solution specifically for oncology clinical trials. The identification of concomitant medication poses specific challenges in oncology data reporting. To address this, CRF Health has incorporated its new TrialMax ConMed™ solution into the platform, allowing patients to report concomitant medication taken during a trial in real-time.

 

 

Read the full release here.

Related Content:

News